These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10190728)
1. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728 [TBL] [Abstract][Full Text] [Related]
2. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154 [TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296 [TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623 [TBL] [Abstract][Full Text] [Related]
6. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation. Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853 [TBL] [Abstract][Full Text] [Related]
7. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function. Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902 [TBL] [Abstract][Full Text] [Related]
8. Serum and ascitic fluid nitrate levels in patients with cirrhosis. Coşkun U; Ozenirler S; Sancak B; Bukan N Clin Chim Acta; 2001 Apr; 306(1-2):127-32. PubMed ID: 11282103 [TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Chan NN; Fuller JH; Rubens M; Colhoun HM Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448 [TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension. Tahan V; Avsar E; Karaca C; Uslu E; Eren F; Aydin S; Uzun H; Hamzaoglu HO; Besisik F; Kalayci C; Okten A; Tozun N World J Gastroenterol; 2003 Oct; 9(10):2325-7. PubMed ID: 14562402 [TBL] [Abstract][Full Text] [Related]
11. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score. Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803 [TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit. Haghjooyjavanmard S; Nematbakhsh M; Monajemi A; Soleimani M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):91-5. PubMed ID: 18795081 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750 [TBL] [Abstract][Full Text] [Related]
14. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461 [TBL] [Abstract][Full Text] [Related]
15. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220 [TBL] [Abstract][Full Text] [Related]
16. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction]. Han YL; Cheng C; Tan HM; Wu WK; Wu YL; Sun HL; Sun J; Chen JL Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270 [TBL] [Abstract][Full Text] [Related]
17. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785 [TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911 [TBL] [Abstract][Full Text] [Related]
19. Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. Curgunlu A; Vural P; Canbaz M; Erten N; Karan MA; Tascioglu C J Clin Lab Anal; 2005; 19(5):177-81. PubMed ID: 16170811 [TBL] [Abstract][Full Text] [Related]
20. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]